fluorobenzenes has been researched along with Angiitis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Debanne, SM; Eckard, AR; Funderburg, NT; Jiang, Y; McComsey, GA | 1 |
Dubé, MP | 1 |
Clagett, B; Debanne, SM; Ferrari, B; Funderburg, NT; Jiang, Y; Juchnowski, S; Labbato, D; Lederman, MM; McComsey, GA; Robinson, J | 1 |
Cremonesi, B; Gelosa, P; Gianazza, E; Gianella, A; Guerrini, U; Nobili, E; Paoletti, R; Sironi, L; Tremoli, E | 1 |
2 trial(s) available for fluorobenzenes and Angiitis
Article | Year |
---|---|
Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Anti-Retroviral Agents; Biomarkers; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Female; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prospective Studies; Pyrimidines; Regression Analysis; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Vasculitis | 2014 |
Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy.
Topics: Adult; Anti-Retroviral Agents; Anticholesteremic Agents; Antigens, CD; Female; Fluorobenzenes; HIV Infections; HLA-DR Antigens; Humans; Male; Middle Aged; Monocytes; Programmed Cell Death 1 Receptor; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; T-Lymphocytes; Treatment Outcome; Vasculitis | 2015 |
2 other study(ies) available for fluorobenzenes and Angiitis
Article | Year |
---|---|
Will statins be an effective anti-inflammatory intervention for prevention of cardiovascular disease in patients with HIV?
Topics: Anti-Retroviral Agents; Cardiovascular Diseases; Female; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vasculitis | 2014 |
Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
Topics: Acute-Phase Proteins; Animals; Cerebral Arteries; Chemokine CCL2; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; P-Selectin; Proteinuria; Pyrimidines; Rats; Rats, Inbred SHR; RNA, Messenger; Rosuvastatin Calcium; Simvastatin; Sodium Chloride, Dietary; Stroke; Sulfonamides; Transcription, Genetic; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vasculitis | 2005 |